p.96 抽出テキスト

49. 日本看護協会.https://www.nurse.or.jp/ 50. Adler A, Novelli V, Amin AS, et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020; 141: 418-428. PMID: 31983240 51. Maron BA, Wang RS, Carnethon MR, et al. What Causes Hypertrophic Cardiomyopathy? Am J Cardiol 2022; 179: 74- 82. PMID: 35843734 52. Westphal DS, Pollmann K, Marschall C, et al. It Is Not Carved in Stone-The Need for a Genetic Reevaluation of Variants in Pediatric Cardiomyopathies. J Cardiovasc Dev Dis 2022; 9: 41. PMID: 35200695 53. Harris SL, Lindsay ME. Role of Clinical Genetic Testing in the Management of Aortopathies. Curr Cardiol Rep 2021; 23: 10. PMID: 33475873 54. Han PKJ, Umstead KL, Bernhardt BA, et al. A taxonomy of medical uncertainties in clinical genome sequencing. Genet Med 2017; 19: 918-925. PMID: 28102863 55. Mishel MH. Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch 1990; 22: 256-262. PMID: 2292449 56. Rhodes A, Rosman L, Cahill J, et al. Minding the Genes: a Multidisciplinary Approach towards Genetic Assessment of Cardiovascular Disease. J Genet Couns 2 0 1 7 ; 2 6 : 2 2 4 - 2 3 1 . PMID: 27695998 57. Makhnoon S, Shirts BH, Bowen DJ. Patients’ perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns 2 0 1 9 ; 2 8 : 3 1 3 - 3 2 5 . PMID: 30636062 58. Hallquist MLG, Tricou EP, Ormond KE, et al. Application of a framework to guide genetic testing communication across clinical indications. Genome Med 2021; 13: 71. PMID: 33926532 59. Miller DT, Lee K, Abul-Husn NS, et al. ACMG Secondary Findings Working Group. ACMG SF v 3. 1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2022; 24: 1407-1414. PMID: 35802134 60. McGill BC, Wakefield CE, Vetsch J, et al. Children and young people’s understanding of inherited conditions and their attitudes towards genetic testing: A systematic review. Clin Genet 2019; 95: 10-22. PMID: 29574695 61. Murray B, Tichnell C, Burch AE, et al. Strength of the genetic counselor: patient relationship is associated with extent of increased empowerment in patients with arrhythmogenic cardiomyopathy. J Genet Couns 2022; 31: 388-397. PMID: 34672408 62. Catchpool M, Ramchand J, Martyn M, et al. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genet Med 2019; 21: 2815-2822. PMID: 31222143 63. Perez MV, Kumarasamy NA, Owens DK, et al. Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome. Circ Cardiovasc Qual Outcomes 2011; 4: 76- 84. PMID: 21139095 64. van den Heuvel LM, van Teijlingen MO, van der Roest W, et al. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions. Circ Genom Precis Med 2020; 13: 524-530. PMID: 33079600 65. Nightingale BM, Hovick SR, Brock P, et al. Hypertrophic cardiomyopathy genetic test reports: A qualitative study of patient understanding of uninformative genetic test results. J Genet Couns 2019; 28: 1087-1097. PMID: 31408576 66. Ho A, Leach E, Virani A, et al. Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort. J Genet Couns 2022; 31: 815-828. PMID: 35032083 67. van den Heuvel LM, Smets EMA, van Tintelen JP, et al. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes. J Genet Couns 2019; 28: 1042-1058. PMID: 31216099 68. Christian S, Somerville M, Huculak C, et al. Practice Variation among an International Group of Genetic Counselors on when to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy. J Genet Couns 2019; 28: 70-79. PMID: 30132189 69. Heliö T, Elliott P, Koskenvuo JW, et al. EORP Cardiomyopathy Registry Investigators Group. ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients. ESC Heart Fail 2020; 7: 3013- 3021. PMID: 32767651 70. van den Heuvel LM, Hoedemaekers YM, Baas AF, et al. A tailored

approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet 2022; 30: 203-210. PMID: 34815540 71. Fusco KM, Hylind RJ, Cirino AL, et al. Cascade testing for inher-

ited cardiac conditions: Risk perception and screening after a negative genetic test result. J Genet Couns 2022; 31: 1273-1281. PMID: 35763674 72. Hey TM, Rasmussen TB, Madsen T, et al. Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives. Circ Heart Fail 2020; 13: e 006701. PMID: 33019804 73. Miller D, Martin LJ, Tretter JT, et al. Uptake of Screening and Recurrence of Bicuspid Aortic Valve and Thoracic Aortic Aneurysm Among At-Risk Siblings of Pediatric Probands. J Pediatr 2021; 239: 219-224. PMID: 34400210 74. Hancock B, Miller EM, Parrott A, et al. Retrospective comparison of parent-reported genetics knowledge, empowerment, and familial uptake of cardiac screening between parents who received genetic counseling by a certified genetic counselor and those who did not: A single US academic medical center study. J Genet Couns 2022; 31: 965-975. PMID: 35261109 75. 日本循環器学会 / 日本産科婦人科学会. 心疾患患者の妊娠・出産の適応,管理に関するガイドライン(2018 年改訂版). https://www. j-circ.or.jp/cms/wp-content/uploads/ 2020/ 02/JCS 2018_akagi_ ikeda.pdf 76. Barker DJ. The origins of the developmental origins theory. J Intern Med 2007; 261: 412-417. PMID: 17444880 77. Johnson K, Posner SF, Biermann J, et al. Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep 2006; 55: 1-23. PMID: 16617292 78. WHO. Preconception care: Maximizing the gains for maternal and child health - Policy brief. https://www.who.int/publications/i/ item/WHO-FWC-MCA-13.02 79. Hanson MA, Bardsley A, De-Regil LM, et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: “Think Nutrition First”. Int J Gynaecol Obstet 2015; 131 Suppl: S 213- S253. PMID: 26433230 80. 荒田尚子.プレコンセプションケア概論.産科と婦人科 2020; 87: 873-880. 81. ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol 2019; 133: e78-e89. PMID: 30575679 82. Farahi N, Zolotor A. Recommendations for preconception counseling and care. Am Fam Physician 2013; 88: 499- 506. PMID: 24364570 83. Pfaller B, Sathananthan G, Grewal J, et al. Preventing Complications in Pregnant Women With Cardiac Disease. J Am Coll Cardiol 2020; 75: 1443-1452. PMID: 32216913 84. Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol 2018; 71: 2419-2430. PMID: 29793631 85. Haberer K, Silversides CK. Congenital Heart Disease and Women’ s Health Across the Life Span: Focus on Reproductive Issues. Can J Cardiol 2019; 35: 1652-1663. PMID: 31813502 86. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006; 92: 1520- 1525. PMID: 16973809 87. European Society of Gynecology (ESG). ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147-3197. PMID: 21873418 88. Drenthen W, Boersma E, Balci A, et al. ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31: 2124-2132. PMID: 20584777 89. Quiñones JN, Walheim L, Mann K, et al. Impact of type of maternal cardiovascular disease on pregnancy outcomes among women managed in a multidisciplinary cardio-obstetrics program. Am J Obstet Gynecol MFM 2021; 3: 100377. PMID: 33932630 90. Lumsden RH, Pagidipati N. Management of cardiovascular risk factors during pregnancy. Heart 2022; 108: 1438- 1444. PMID: 35064047 91. Ishibashi K, Aiba T, Kamiya C, et al. Arrhythmia risk and β -blocker therapy in pregnant women with long QT syndrome. Heart 2017; 103: 1374-1379. PMID: 28292826 92. Neki R, Fujita T, Kokame K, et al. Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol 2011; 94: 150-155. PMID: 21811774 93. 小林隆夫,森下英理子,津田博子,他.遺伝性血栓性素因患者の妊